Trial intelligence / Profile preview

Phenazopyridine for In-office Cystoscopy

NCT02715648Unknown

Sponsor
Boston Urogynecology Associates
Start
Apr 2016
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of phenazopyridine (2 arms), sponsored by Boston Urogynecology Associates. Primary endpoint: Total cystoscopy time. Status: unknown.

02

Drugs

phenazopyridine

Beyond the preview

Go deeper on NCT02715648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02715648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call